DNLI FY2025 EPS Forecast Increased by Cantor Fitzgerald
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Research analysts at Cantor Fitzgerald upped their FY2025 earnings estimates for shares of Denali Therapeutics in a report issued on Wednesday, May 7th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will post earnings per share of ($2.97) for the year, up from their prior […]
